Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ITRM holding history

Iterum Therapeutics plc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITRM overviewAll 13F holders of ITRMFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ITRM by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,201−100.0%Sold outHolders
Q1 20263,201$96<0.1%−116,747−97.3%ReducedHolders
Q4 2025119,948$40.2K<0.1%+111,322+1,290.5%AddedHolders
Q3 20258,626$5.78K<0.1%−173−2.0%ReducedHolders
Q2 20258,799$8.76K<0.1%+100+1.1%AddedHolders
Q1 20258,699$10.7K<0.1%+5,625+183.0%AddedHolders
Q4 20243,074$5.44K<0.1%+3,073+307,300.0%AddedHolders
Q3 20241$1<0.1%00.0%UnchangedHolders
Q2 20241$1<0.1%−12,018−100.0%ReducedHolders
Q1 202412,019$18.5K<0.1%+7,070+142.9%AddedHolders
Q4 20234,949$9.75K<0.1%+4,949NewHolders
Q3 20230$00.0%−48−100.0%Sold outHolders
Q2 202348$51<0.1%+42+700.0%AddedHolders
Q1 20236$6<0.1%−15,258−100.0%ReducedHolders
Q4 202215,264$12.8K<0.1%+6,943+83.4%AddedHolders
Q3 20228,321$13.0K<0.1%+8,321+12,481,400.0%AddedConverted for a 1-for-15 splitHolders
Q2 20221$00.0%−29,484−100.0%ReducedHolders
Q1 202229,485$10.0K<0.1%−35,521−54.6%ReducedHolders
Q4 202165,006$25.0K<0.1%+52,921+437.9%AddedHolders
Q3 202112,085$7.00K<0.1%−17,148−58.7%ReducedHolders
Q2 202129,233$68.0K<0.1%−23,728−44.8%ReducedHolders
Q1 202152,961$75.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.